TCIM
AST
TIAA CREF Investment Management’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-83,337
| Closed | -$121K | – | 3215 |
|
2018
Q1 | $121K | Hold |
83,337
| – | – | ﹤0.01% | 3006 |
|
2017
Q4 | $188K | Buy |
83,337
+7,285
| +10% | +$16.4K | ﹤0.01% | 3006 |
|
2017
Q3 | $259K | Buy |
76,052
+3,029
| +4% | +$10.3K | ﹤0.01% | 3018 |
|
2017
Q2 | $259K | Buy |
73,023
+4,821
| +7% | +$17.1K | ﹤0.01% | 3060 |
|
2017
Q1 | $232K | Sell |
68,202
-2,438
| -3% | -$8.29K | ﹤0.01% | 2966 |
|
2016
Q4 | $325K | Sell |
70,640
-13,938
| -16% | -$64.1K | ﹤0.01% | 2962 |
|
2016
Q3 | $359 | Hold |
84,578
| – | – | ﹤0.01% | 2960 |
|
2016
Q2 | $203K | Buy |
84,578
+55,082
| +187% | +$132K | ﹤0.01% | 3091 |
|
2016
Q1 | $139K | Hold |
29,496
| – | – | ﹤0.01% | 3019 |
|
2015
Q4 | $116K | Hold |
29,496
| – | – | ﹤0.01% | 3099 |
|
2015
Q3 | $114K | Buy |
29,496
+25,446
| +628% | +$98.3K | ﹤0.01% | 3069 |
|
2015
Q2 | $19K | Sell |
4,050
-457
| -10% | -$2.14K | ﹤0.01% | 3217 |
|
2015
Q1 | $30K | Hold |
4,507
| – | – | ﹤0.01% | 3106 |
|
2014
Q4 | $15K | Buy |
+4,507
| New | +$15K | ﹤0.01% | 3140 |
|